Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Inotiv Inc (NOTV)

32.86   0.7 (2.18%) 01-16 04:46
Open: 31.71 Pre. Close: 32.16
High: 33.245 Low: 31.6017
Volume: 78,321 Market Cap: 811M
Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segment offers screening and pharmacological testing, nonclinical safety testing, formulation development, regulatory compliance, and quality control testing services. This segment provides analytical method development and validation; drug metabolism, bioanalysis, and pharmacokinetics testing to identify and measure drug and metabolite concentrations in complex biological matrices; in vivo sampling services for the continuous monitoring of chemical changes in life; stability testing to ensure the integrity of various solutions used in nonclinical and clinical studies, and post-study analyses; non-clinical toxicology and pathology services; and climate-controlled archiving services for its customers' data and samples. The Research Products segment designs, develops, manufactures, and markets in vivo sampling systems and accessories, including disposables, training, and systems qualification; physiology monitoring tools; liquid chromatography and electrochemistry instruments platforms; analytical products comprising liquid chromatographic and electrochemical instruments with associated accessories; and in vivo sampling products consisting of Culex family of automated in vivo sampling and dosing instruments. The company operates in the United States, rest of North America, the Pacific Rim, Europe, and internationally. It has an agreement with BioVaxys to conduct preclinical toxicity studies for its Covid-T Immunodiagnostic program. The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021. Inotiv, Inc. was founded in 1974 and is headquartered in West Lafayette, Indiana.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 33.257 - 33.421 33.421 - 33.587
Low: 31.225 - 31.39 31.39 - 31.558
Close: 32.587 - 32.856 32.856 - 33.128

Technical analysis

as of: 2022-01-15 8:48:30 PM
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 51.24     One year: 60.09
Support: Support1: 31.60    Support2: 26.29
Resistance: Resistance1: 43.87    Resistance2: 51.45
Pivot: 37.53
Moving Average: MA(5): 33.85     MA(20): 38.86
MA(100): 40.59     MA(250): 29.91
MACD: MACD(12,26): -3.56     Signal(9): -3.06
Stochastic oscillator: %K(14,3): 8.74     %D(3): 12.20
RSI: RSI(14): 32.51
52-week: High: 60.66  Low: 11.21  Change(%): 119.7
Average Vol(K): 3-Month: 20238  10-Days: 16032

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
NOTV has closed above bottom band by 19.6%. Bollinger Bands are 8.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 10 Jan 2022
Inotiv, Inc. Announces Expansion of Safety Assessment Offerings with Acquisition of Integrated Laboratory Systems, LLC - GlobeNewswire

Fri, 17 Dec 2021
Inotiv Swings to Full-Year Profit - Inside INdiana Business

Wed, 08 Dec 2021
Inotiv Stock (NOTV): Why The Price Surged Today - Pulse 2.0

Fri, 05 Nov 2021
Inotiv, Inc. Completes Purchase of Envigo - GlobeNewswire

Tue, 02 Nov 2021
Inotiv, Inc. to Participate in Upcoming Investor Conferences - GlobeNewswire

Tue, 26 Oct 2021
Should You Buy Inotiv Inc (NOTV) Stock on Tuesday? - InvestorsObserver

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Outperform
Return on Equity: Outperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Diagnostics & Research
Shares Out. (M) 24
Shares Float (M) 8
% Held by Insiders 50.88
% Held by Institutions 76.19
Shares Short (K) 2,110
Shares Short P. Month (K) 1,760

Stock Financials

EPS -0.430
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 5.600
Profit Margin -6.83
Operating Margin -1.66
Return on Assets (ttm) -0.7
Return on Equity (ttm) -10.5
Qtrly Rev. Growth 45.2
Gross Profit (p.s.) 0.754
Sales Per Share 3.114
EBITDA (p.s.) 0.141
Qtrly Earnings Growth
Operating Cash Flow (M) 8
Levered Free Cash Flow (M) -1

Stock Valuations

PE Ratio -76.42
PEG Ratio
Price to Book value 5.87
Price to Sales 10.55
Price to Cash Flow 102.52

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.